Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

19 May 2011 10:00

RNS Number : 9111G
British Smaller Companies VCT2 Plc
19 May 2011
 



 

British Smaller Companies VCT2 plc ("the Company")

 

Interim Management Statement

For the quarter ended 31 March 2011

 

British Smaller Companies VCT2 plc presents its interim management statement for the quarter ended 31 March 2011. This constitutes the Company's first interim management statement for the financial year ending 31 December 2011, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmep.co.uk.

 

The total return at 31 March 2011, calculated by reference to the net asset value per share and the cumulative dividends paid and proposed, is 94.9 pence per share an increase of 0.5 pence per share in the quarter.

 

The unaudited net asset value per Ordinary share as at 31 March 2011 was 68.9p (31 December 2010: 68.4p). The 0.5p increase this quarter is the net result of a 1.3p per share increase in the value of the investments an operating loss of 0.3p and the 0.5p dilutive impact of the issue of shares.

 

The number of Ordinary shares in issue at 31 March 2011 was 20,934,196 (31 December 2010: 17,278,696). In addition at 31 March 2011 the Company held 566,100 shares in Treasury (31 December 2010: 566,100)

 

During the quarter the company raised £2.57 million by issuing 3,655,500 Ordinary Shares at a price of 70.25p per share pursuant to its linked offer for subscription with British Smaller Companies VCT plc ("Linked Offer").

 

Subsequent to the quarter end, pursuant to the Linked Offer, a further £1.35 million was raised by issuing a further 1,921,901 shares on 5 April 2011 and a final £0.47 million was raised through the issue of 690,699 shares on 4 May 2011 at a price of 70.25p per share. The Linked Offer for both the tax year 2010/2011 and 2011/2012 is now closed.

 

In addition, the Company purchased 191,280 Ordinary shares of 10 pence each at a price of 58.25 pence per share. These shares were placed in Treasury.

 

Net assets at 31 March 2011 comprised the following:

 

£000

% of net assets

Unquoted investments at fair value

5,851

40.6

Quoted investments at bid price

1,347

9.3

Gilt investments

3,957

27.4

Total investments

11,155

77.3

Cash and cash equivalents

3,047

21.1

Other net current assets (liabilities)

231

1.6

Net assets

14,433

100.0

 

The ten largest investments by valuation at 31 March 2011 were as follows:

 

£000

% of net assets

Digital Healthcare Limited

1,128

7.8

Primal Pictures Limited

1,082

7.5

Immunobiology Limited

1,002

6.9

Deep-Secure Ltd

546

3.8

Bluebell Telecom Group Limited

500

3.5

Waterfall Services Limited

455

3.2

Pressure Technologies plc

450

3.1

Harvey Jones Limited

350

2.4

Brady plc

304

2.1

Sirigen Limited

267

1.9

Top ten investments

6,084

42.2

Other investments

1,114

7.7

Gilt investments

3,957

27.4

Total investments

11,155

77.3

 

Quoted investments are carried at bid price at 31 March 2011 less a discount for liquidity where necessary. Unquoted investment are carried at fair value as 31 March 2011 as determined by the directors.

 

There were no investments or disposals during the three months ended 31 March 2011.

 

Performance

 

In this period the Company has seen its net asset value increase by 0.5p per share. The net asset value excluding the impact of the new issue of shares increased by 1.0p per share (1.5%), with increases seen in both the unquoted and quoted portfolios.

 

The total return, calculated by reference to the net asset value plus cumulative dividend paid and proposed has increased by 0.5p to 94.9p per share, of which cumulative dividends represent 28.0p per share.

 

The net asset value currently comprises 48.8% in cash and gilts which in the short term will further increase following the share allotments and as such the Company is well placed to take advantage of selective investment opportunities as they arise enabling it to further diversify its portfolio of investments.

 

Dividend Re-investment scheme

 

The Company recently introduced a dividend re-investment scheme. Should the final dividend be approved at the AGM this will be the first dividend eligible under the scheme.

 

Share Buyback Policy

 

Prior to the Annual General Meeting held on 16 May 2011 the board of Directors withdrew the resolution proposed in the notice of the Annual General Meeting to renew the Company's authority to purchase its own shares. Although a majority of shareholders voting, including those voting by proxy, had indicated their support for the proposal, a significant minority were opposed. With this in mind the Directors withdrew the resolution prior to the meeting and intend to consult with shareholders in the coming months with a view to obtaining the necessary authority to re-introduce the share buyback policy. A further announcement will be made, as appropriate, in due course.

 

Investor Workshops

 

The Company remains committed to enhancing Shareholder communications and has presented annual investor workshops for a number of years which have proved very popular with Shareholders. The most recent event held on 9 February 2011 at the British Museum welcomed over 150 Shareholders.

 

Outlook

 

The Company has raised a total of £4.02m from the recent Linked Offer with British Smaller Companies VCT plc which will be used to support and diversify the investment portfolio over the coming years.

 

There is increasing evidence of businesses searching for capital and looking to expand which your Board believes will translate into increasing investment opportunities over both the short and medium term. The Company is well placed to take advantage of these investment opportunities as well as continuing to support its existing investments.

 

 

19 May 2011

 

For further information please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 294 5039

Jeff Keating Singer Capital Markets Limited Tel: 0203 205 7500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMKRLNGMZG
Date   Source Headline
23rd Sep 201910:10 amRNSPayment of Dividend and Issue of Equity
14th Aug 20199:14 amRNSHalf-year Report
10th May 20199:43 amRNSPayment of Final Dividend and Issue of Equity
7th May 20192:18 pmRNSResult of AGM and Change of Chairman
7th May 20199:53 amRNSInterim Management Statement
4th Apr 201912:13 pmRNSDirector/PDMR Shareholding
4th Apr 201912:13 pmRNSDirector/PDMR Shareholding
4th Apr 201912:11 pmRNSDirector/PDMR Shareholding
4th Apr 201912:10 pmRNSDirector/PDMR Shareholding
1st Apr 20193:51 pmRNSIssue of Equity
1st Apr 20193:44 pmRNSIssue of Equity and Close of Offers
27th Mar 201910:19 amRNSTransaction in Own Shares and Net Asset Value
26th Mar 20194:29 pmRNSPublication of Supplementary Prospectus
26th Mar 20194:27 pmRNSPublication of Supplementary Prospectus
22nd Mar 201911:48 amRNSAnnual Financial Report
6th Mar 201911:09 amRNSAppointment of non-executive director
15th Feb 20199:56 amRNSPayment of interim dividend and issue of shares
11th Feb 201911:15 amRNSClose of Offers to New Applications
11th Feb 201911:15 amRNSClose of Offers to New Applications
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
7th Jan 20192:15 pmRNSDividend Declaration
7th Jan 20191:15 pmRNSStatement re Prospectus
7th Jan 20191:15 pmRNSStatement re Prospectus
21st Dec 20189:13 amRNSDisposal
20th Dec 201810:20 amRNSTransaction in Own Shares
27th Nov 20186:07 pmRNSPublication of Prospectus
27th Nov 20185:49 pmRNSPublication of Prospectus
21st Nov 20181:00 pmRNSUnaudited Interim Results to 30 September 2018
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
28th Sep 20189:54 amRNSPayment of dividend and allotment of shares
27th Sep 20181:27 pmRNSTransaction in Own Shares
17th Aug 20188:07 amRNSHalf-year Report
25th Jun 201811:52 amRNSTransaction in Own Shares
11th May 201810:01 amRNSPayment of final dividend and allotment of shares
9th May 20182:36 pmRNSResult of Annual General meeting
9th May 20189:54 amRNSInterim Management Statement
28th Mar 20188:27 amRNSTransaction in Own Shares
16th Mar 20181:43 pmRNSAnnual Financial Report
16th Feb 20189:50 amRNSIssue of Equity
12th Feb 201810:50 amRNSDirector Declaration
26th Jan 20189:24 amRNSClose of Offer to New Subscriptions
11th Jan 20188:06 amRNSOffer for Subscription
20th Dec 20178:50 amRNSPurchase of own securities and total voting rights
20th Dec 20178:50 amRNSLaunch of Top-up Offer
30th Nov 20171:28 pmRNSInterim Management Statement to 30 September 2017
20th Oct 20172:12 pmRNSTransaction in Own Shares
29th Sep 20179:47 amRNSPayment of interim dividend and issue of shares
29th Sep 20179:36 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.